NCT00299208View on ClinicalTrials.gov

Azithromycin Combination Therapy for Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

Not specified

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Plasmodium Falciparum Malaria
Interventions
DRUG

Artesunate

DRUG

Azithromycin

DRUG

Quinine

Trial Locations (1)

10270

Mahidol University Hospital for Tropical Diseases, Bangkok

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00299208 - Azithromycin Combination Therapy for Malaria | Biotech Hunter | Biotech Hunter